Quetiapine operates chiefly as an antagonist at several neurotransmitter receptors in the brain: serotonin (5-HT) receptors, dopamine receptors, and adrenergic receptors, among others. By tempering the overactivity of dopamine, which is often associated with psychosis, and enhancing serotonin activity, quetiapine brings a sense of equilibrium to the dysregulated pathways that contribute to the symptoms of mental health disorders. This delicate recalibration can ease the torment of hallucinations, delusions, and mood swings, affording patients the possibility of a more centered and serene existence.